# Prophylactic Ethanol Lock Therapy (ELT) in Patients on Home Parenteral Nutrition

> **NCT02227329** · PHASE1,PHASE2 · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 39 (actual)

## Conditions studied

- Catheter-related Bloodstream Infection (CRBSI) Nos
- Bloodstream Infection Due to Central Venous Catheter
- Bloodstream Infection Due to Hickman Catheter

## Interventions

- **DRUG:** Ethanol
- **DRUG:** Heparin Lock
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT02227329
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-07
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 39 (ACTUAL)
- **Why stopped:** Publication of guidelines advising against the use of ethanol locks.
- **Last updated:** 2017-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02227329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02227329, "Prophylactic Ethanol Lock Therapy (ELT) in Patients on Home Parenteral Nutrition". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02227329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*